Abstract
The bronchodilatation achieved by the beta 2 agonist terbutaline sulphate given as nebulised aerosol from different devices has been measured in seven patients with mild asthma (mean FEV1 76% predicted) over two hours after inhalation. The subjects were studied on four occasions. On three visits they received 2.5 mg terbutaline delivered from three different types of nebuliser, selected on the basis of the size distribution of the aerosols generated; and on a fourth (control) visit no aerosol was given. The size distributions of the aerosols expressed in terms of their mass median diameter (MMD) were: A: MMD 1.8 microns; B: 4.6 microns; C: 10.3 microns. The aerosols were given under controlled conditions of respiratory rate and tidal volume to minimise intertreatment variation. Bronchodilator response was assessed by changes in FEV1, forced vital capacity (FVC), peak expiratory flow (PEF), and maximal flow after expiration of 50% and 75% FVC (Vmax50, Vmax25) from baseline (before aerosol) and control run values. For each pulmonary function index all three aerosols gave significantly better improvement over baseline than was seen in the control (p less than 0.05) and had an equipotent effect on FEV1, FVC, and PEF. Aerosol A (MMD 1.8 microns) produced significantly greater improvements in Vmax50 and Vmax25 than did B or C (p less than 0.05). These results suggest that for beta 2 agonists small aerosols (MMD less than 2 microns) might be advantageous in the treatment of asthma.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Barnes P. J., Basbaum C. B., Nadel J. A., Roberts J. M. Localization of beta-adrenoreceptors in mammalian lung by light microscopic autoradiography. Nature. 1982 Sep 30;299(5882):444–447. doi: 10.1038/299444a0. [DOI] [PubMed] [Google Scholar]
- Clay M. M., Pavia D., Newman S. P., Clarke S. W. Factors influencing the size distribution of aerosols from jet nebulisers. Thorax. 1983 Oct;38(10):755–759. doi: 10.1136/thx.38.10.755. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Douglas J. G., Leslie M. J., Crompton G. K., Grant I. W. Is the flow rate used to drive a jet nebuliser clinically important? Br Med J (Clin Res Ed) 1985 Jan 5;290(6461):29–29. doi: 10.1136/bmj.290.6461.29. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Godfrey S., Zeidifard E., Brown K., Bell J. H. The possible site of action of sodium cromoglycate assessed by exercise challenge. Clin Sci Mol Med. 1974 Feb;46(2):265–272. doi: 10.1042/cs0460265. [DOI] [PubMed] [Google Scholar]
- Hensley M. J., O'Cain C. F., McFadden E. R., Jr, Ingram R. H., Jr Distribution of bronchodilatation in normal subjects: beta agonist versus atropine. J Appl Physiol Respir Environ Exerc Physiol. 1978 Nov;45(5):778–782. doi: 10.1152/jappl.1978.45.5.778. [DOI] [PubMed] [Google Scholar]
- Keighley J. F. Response to sympathomimetic aerosols of differing particle size in subjects with chronic bronchitis. Am Rev Respir Dis. 1968 Nov;98(5):879–882. doi: 10.1164/arrd.1968.98.5.879. [DOI] [PubMed] [Google Scholar]
- Knudson R. J., Burrows B., Lebowitz M. D. The maximal expiratory flow-volume curve: its use in the detection of ventilatory abnormalities in a population study. Am Rev Respir Dis. 1976 Nov;114(5):871–879. doi: 10.1164/arrd.1976.114.5.871. [DOI] [PubMed] [Google Scholar]
- Pavia D., Thomson M. L., Clarke S. W., Shannon H. S. Effect of lung function and mode of inhalation on penetration of aerosol into the human lung. Thorax. 1977 Apr;32(2):194–197. doi: 10.1136/thx.32.2.194. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ruffin R. E., Obminski G., Newhouse M. T. Aerosol salbutamol administration by IPPB: lowest effective dose. Thorax. 1978 Dec;33(6):689–693. doi: 10.1136/thx.33.6.689. [DOI] [PMC free article] [PubMed] [Google Scholar]